Correlation Engine 2.0
Clear Search sequence regions


  • antigen (4)
  • antigen t (2)
  • cd8 receptor (2)
  • cell (7)
  • cellular (1)
  • Hep (1)
  • humans (1)
  • Interferon gamma (2)
  • mice (1)
  • NS3 (1)
  • patients (2)
  • peptides (3)
  • peptides t (2)
  • receptor (1)
  • receptors antigen (2)
  • t cell receptor (4)
  • t lymphocytes (11)
  • TCR (14)
  • virus (4)
  • Sizes of these terms reflect their relevance to your search.

    T-cell receptor (TCR)-pMHC affinity has been generally accepted to be the most important factor dictating antigen recognition in gene-modified T-cells. As such, there is great interest in optimizing TCR-based immunotherapies by enhancing TCR affinity to augment the therapeutic benefit of TCR gene-modified T-cells in cancer patients. However, recent clinical trials using affinity-enhanced TCRs in adoptive cell transfer (ACT) have observed unintended and serious adverse events, including death, attributed to unpredicted off-tumor or off-target cross-reactivity. It is critical to re-evaluate the importance of other biophysical, structural, or cellular factors that drive the reactivity of TCR gene-modified T-cells. Using a model for altered antigen recognition, we determined how TCR-pMHC affinity influenced the reactivity of hepatitis C virus (HCV) TCR gene-modified T-cells against a panel of naturally occurring HCV peptides and HCV-expressing tumor targets. The impact of other factors, such as TCR-pMHC stabilization and signaling contributions by the CD8 co-receptor, as well as antigen and TCR density were also evaluated. We found that changes in TCR-pMHC affinity did not always predict or dictate IFNγ release or degranulation by TCR gene-modified T-cells, suggesting that less emphasis might need to be placed on TCR-pMHC affinity as a means of predicting or augmenting the therapeutic potential of TCR gene-modified T-cells used in ACT. A more complete understanding of antigen recognition by gene-modified T-cells and a more rational approach to improve the design and implementation of novel TCR-based immunotherapies is necessary to enhance efficacy and maximize safety in patients.

    Citation

    Timothy T Spear, Yuan Wang, Kendra C Foley, David C Murray, Gina M Scurti, Patricia E Simms, Elizabeth Garrett-Mayer, Lance M Hellman, Brian M Baker, Michael I Nishimura. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells. Cancer immunology, immunotherapy : CII. 2017 Nov;66(11):1411-1424

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28634816

    View Full Text